Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P16144
UPID:
ITB4_HUMAN
Alternative names:
GP150
Alternative UPACC:
P16144; A0AVL6; O14690; O14691; O15339; O15340; O15341; Q0VF97; Q9UIQ4
Background:
Integrin beta-4, also known as GP150, plays a pivotal role in the structural integrity of epithelial cells through its function as a receptor for laminin. It is crucial for keratinocyte polarity and motility, engaging in essential signaling pathways with NRG1, IGF1, and IGF2.
Therapeutic significance:
The involvement of Integrin beta-4 in junctional epidermolysis bullosa types 5A and 5B highlights its critical role in skin and mucosal health. Understanding its mechanisms opens avenues for targeted therapies in these debilitating skin disorders.